Stocks and Investing Stocks and Investing
Wed, November 24, 2021
Tue, November 23, 2021
Mon, November 22, 2021
Sun, November 21, 2021
Sat, November 20, 2021
Fri, November 19, 2021

Mani Foroohar Maintained (BBIO) at Buy with Decreased Target to $66 on, Nov 19th, 2021


Published on 2024-10-27 18:43:17 - WOPRAI, Mani Foroohar
  Print publication without navigation


Mani Foroohar of SVB Leerink, Maintained "BridgeBio Pharma, Inc." (BBIO) at Buy with Decreased Target from $68 to $66 on, Nov 19th, 2021.

Mani has made no other calls on BBIO in the last 4 months.



There are 2 other peers that have a rating on BBIO. Out of the 2 peers that are also analyzing BBIO, 0 agree with Mani's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Mani


  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $88 on, Monday, October 25th, 2021
  • Geoff Meacham of "B of A Securities" Upgraded from Hold to Strong Buy and Held Target at $75 on, Friday, September 10th, 2021